ICICI Securities research report on Blue Jet Healthcare: Blue Jet Healthcare’s (BlueJet) Q2FY25 shows a ramp-up in contrast media as ABA HCL volumes normalise; the segment should see acceleration in growth with the commissioning of intermediate for NCE MRI molecule and iodinated ABA HCL from Q4FY25. BlueJet’s PI/API segment shone bright with higher volumes from cardiovascular molecule.
Open Flip
Rail Vikas Nigam Limited‘s shares surged on Tuesday after the company emerged as the lowest bidder for a project in South Central railway. What Happened: RVNL on Monday announced it became the lowest bidder for an Engineering, Procurement and Construction (EPC) contract from South Central Railway. The project involves doubling the track between Parbhani to Parli stations in Maharashtra.
Open Flip
As almost half of NSE100 companies that have released their September quarter results have missed expectations by over 4%, global brokerage firm Bernstein has predicted a further decline in the Indian stock market. Asking investors to acknowledge the slowdown, the brokerage said earnings misses have been a secular trend across sectors, barring banks which are helped by larger names.
Open Flip
